Funding to rebuild health stockpiles has increased under Biden, but more work needed to meet promise
When the COVID-19 pandemic hit the United States in March 2020, it exposed the shortcomings of the nation's stockpile of emergency medical supplies.
The INFORMS Analytics+ Conference showcased how companies are turning advanced analytics and AI into measurable operational results
In most emergency departments, beds are a hot commodity. But some patients don’t actually need a bed for their treatment – and accurately identifying those people is a low-lift but effective way to increase efficiency without sacrificing care quality, finds a study recently published in the journal Management Science.
The researchers developed a simple decision tree, informed by mathematical and machine learning models, to help staff decide whether a patient truly needs a bed or can be routed to a “vertical processing pathway” – that is, an area where they can be treated sitting up. Many hospitals already have such an area but don’t necessarily have a systematic way to decide which patients are treated there.
Diversity alone won’t get the votes for funding public education. It takes communities that are more integrated and connected, where residents have a sense of shared stake.
An audio journey of how data and analytics save lives, save money and solve problems.

Jeff Cohen
Chief Strategy Officer
INFORMS
Catonsville, MD
[email protected]
443-757-3565
Explore our resources for multiple topics including:
When the COVID-19 pandemic hit the United States in March 2020, it exposed the shortcomings of the nation's stockpile of emergency medical supplies.
With demand for its COVID-19 vaccine decreasing, Johnson & Johnson (J&J) has begun scaling back production of the shots. In the past few months, the New Brunswick, New Jersey-based pharmaceutical company has terminated manufacturing agreements with companies that helped to produce the vaccine during the pandemic, including Catalent and Sanofi.
Beijing’s rapid U-turn on its zero-Covid policies created a gap in supplies of Pfizer, Merck medicines that health authorities are struggling to close
Imagine using technology that never forgets a face, while improving airport security and shortening lines. Such technology exists and may be coming to an airport near you.
Drugmaker ends production contracts, and is in arbitration with Merck

OR/MS Today is the INFORMS member magazine that shares the latest research and best practices in operations research, analytics and the management sciences.
Access OR/MS Today Magazine
Analytics magazine showcases articles and research reports based on big data, AI, machine learning, data analytics and other new-age technologies.
Access Analytics Magazine